Sign in
CompletedNo phase

Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and Tetraplegia

Key facts

Who runs it
Wandercraft
Where
France3 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
35 people enrolled
Started
1 Jun 2024
Ended
1 Sept 2024
Type of study
Observational
Treatments tested
  • Hands-free exoskeleton
Record updated
23 April 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • ≥18 years old,
  • Tetraplegia or high paraplegia (at or above T4) regardless of the cause,
  • Non-opposition to the participation to the study,
  • Having undergone a minimum of 1 session with the Atalante device from February 2019, to now

Who cannot take part

  • Neurological Level of Injury below T4 as determined by the International Standards for Neurological Classification of SCI

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The objective of this clinical trial is to determine whether the Atalante X exoskeleton can be safely utilized by patients with tetraplegia and high paraplegia (at or above T4).

The group in the trial

  • Hands-free exoskeleton

    Patient with high paraplegia or tetraplegia who have undergone at least one session with the exoskeleton.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
23 April 2025